CD4 and myasthenia gravis: Although PD-1 positivity on CD4+ T cells was not affected significantly from IS treatment, PD-1+CXCR5+cells (cTfh cells) were higher in the untreated than in the treated patients (p = 0.012) and the HC (p = 0.001) in AChR-MG.